Plain-English translation of NCT07060547 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a blood-based test called HepQuant DuO to see how well it can measure liver function and recovery in people with alcohol-related liver disease. The test involves drinking a natural compound called cholate and having blood samples taken at specific times. Researchers want to understand whether this test can help doctors better monitor and treat patients with liver damage from alcohol use.
Doctors currently have limited tools to precisely measure how well a damaged liver is recovering and functioning. This study aims to see whether the HepQuant DuO test can provide better information to help guide treatment decisions and track improvement over time.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic 4 times over one year — at 1, 3, 6, and 12 months after enrolling. At each visit, you'll receive the HepQuant DuO test (drinking a natural compound and having blood drawn twice) along with standard liver function tests. The study team will also ask you about your alcohol use, any symptoms you're experiencing, and how the condition is affecting your quality of life.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States